Clinical mass spectrometry
for neurosciences

unites an outstanding team of Munich-based experts in proteomics, medicine and bioinformatics to translate mass spectrometry-based proteomics into clinical practice. With a biological-medical focus on diseases of the nervous system the overarching goals of CLINSPECT-M are to demonstrate that mass spectrometry in systems medicine i) is technically and logistically feasible ii) generates novel insights into disease biology iii) uncovers biomarkers for diagnosis, prognosis and treatment response and iv) provides short-, medium- and long-term clinical translation opportunities aiding clinical decision making for individual patients.